查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1982809

2026-2034年全球藥品安全監測和藥品安全軟體市場規模、佔有率、趨勢和成長分析報告

Global Pharmacovigilance and Drug Safety Software Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 136 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計藥物警戒和藥物安全軟體市場將從 2025 年的 2.5614 億美元成長到 2034 年的 4.8332 億美元，2026 年至 2034 年的複合年成長率為 7.31%。

隨著製藥公司日益重視藥物安全監測和法規遵循，全球藥物警戒和藥物安全軟體市場正顯著成長。藥物警戒軟體有助於確保在藥物的整個生命週期內進行不利事件追蹤、安全資料管理以及符合監管準則。

推動市場擴張的因素有很多。藥物研發活動的增加和監管要求的日益嚴格催生了對先進安全監測系統的需求。此外，臨床試驗和上市後調查計畫的複雜性不斷提高，也促使製藥公司採用自動化解決方案進行藥物安全管理。

隨著製藥公司持續將患者安全和合規性放在首位，藥物警戒和藥物安全軟體市場預計將會成長。數據分析和人工智慧的進步有望提升檢測安全訊號和管理大規模資料集的能力。此外，全球醫藥市場的擴張預計也將支撐市場需求的持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球藥品安全監測與藥品安全軟體市場：功能

  • 市場分析、洞察與預測
  • 病例資料的收集和管理
  • 不利事件的報告和分析
  • 訊號偵測及其他安全風險評估

第5章 全球藥品安全監測與藥品安全軟體市場：依交付類型分類

  • 市場分析、洞察與預測
  • 現場
  • 一經請求

第6章 全球藥品安全監測與藥品安全軟體市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫療保健公司（製藥和生物技術公司）
  • CRO/BPO 或 PV服務供應商（如果外包）
  • 其他

第7章 全球藥品安全監測與藥品安全軟體市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • IQVIA
    • Accenture
    • Cognizant
    • Laboratory Corporation Of America Holdings
    • IBM
    • ArisGlobal
    • ICON Plc
    • Capgemini
    • Oracle
    • Parexel International Corporation
簡介目錄
Product Code: VMR11212598

The Pharmacovigilance and Drug Safety Software Market size is expected to reach USD 483.32 Million in 2034 from USD 256.14 Million (2025) growing at a CAGR of 7.31% during 2026-2034.

The global pharmacovigilance and drug safety software market has grown significantly as pharmaceutical companies focus on monitoring drug safety and regulatory compliance. Pharmacovigilance software helps track adverse drug reactions, manage safety data, and ensure compliance with regulatory guidelines throughout the lifecycle of pharmaceutical products.

Several factors are driving the expansion of this market. Increasing drug development activities and stricter regulatory requirements have created demand for advanced safety monitoring systems. Additionally, the growing complexity of clinical trials and post-marketing surveillance programs has encouraged pharmaceutical companies to adopt automated drug safety software solutions.

Looking ahead, the pharmacovigilance and drug safety software market is expected to grow as pharmaceutical companies continue prioritizing patient safety and regulatory compliance. Advances in data analytics and artificial intelligence may improve the ability to detect safety signals and manage large datasets. Furthermore, the expansion of global pharmaceutical markets will likely support continued demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Functionality

  • Case Data Collection and Management
  • Adverse Event Reporting and Analysis
  • Signal Detection and Other Safety Risk Assessment

By Delivery Mode

  • On Premise
  • On Demand

By End Use

  • Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
  • CROs/BPOs or PV Service Providers When Outsourced
  • Others

COMPANIES PROFILED

  • IQVIA, Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM, ArisGlobal, ICON Plc, Capgemini, Oracle, Parexel International Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY FUNCTIONALITY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Functionality
  • 4.2. Case Data Collection and Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Adverse Event Reporting and Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Signal Detection and Other Safety Risk Assessment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY DELIVERY MODE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Delivery Mode
  • 5.2. On Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. On Demand Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Healthcare Companies (Pharmaceuticals & Biotechnology Companies) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. CROs/BPOs or PV Service Providers When Outsourced Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Functionality
    • 7.2.2 By Delivery Mode
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Functionality
    • 7.3.2 By Delivery Mode
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Functionality
    • 7.4.2 By Delivery Mode
    • 7.4.3 By End Use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Functionality
    • 7.5.2 By Delivery Mode
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Functionality
    • 7.6.2 By Delivery Mode
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 IQVIA
    • 9.2.2 Accenture
    • 9.2.3 Cognizant
    • 9.2.4 Laboratory Corporation Of America Holdings
    • 9.2.5 IBM
    • 9.2.6 ArisGlobal
    • 9.2.7 ICON Plc
    • 9.2.8 Capgemini
    • 9.2.9 Oracle
    • 9.2.10 Parexel International Corporation